Republican Sen. Dave McCormick visited Pittsburgh on Monday to tour the city’s life sciences facilities with National Institutes of Health Director Dr. Jay Bhattacharya to highlight the jobs, medical breakthroughs and economic growth federal research investment brings.
Mr. McCormick and Dr. Bhattacharya visited the UPMC Vision Institute, the UPMC Rehabilitation Institute, and the UPMC Hillman Cancer Center, where they met researchers working on advancements in new cancer treatments and prevention.
Afterward, they met with biotech business leaders, university executives, philanthropists, hospital administrators and investors to discuss how NIH funding has driven growth in the biotechnology sector across the region, which is pivotal in the global competition with China to become the worldwide leader in life sciences, they said.
“If we don’t continue to be in the lead, that has real dire consequences for America relative to the rest of the world,” Mr. McCormick said.
Monday’s tour through Pittsburgh’s research and biotech facilities was the first leg of a two-day tour of life sciences facilities across the state for Mr. McCormick and Dr. Bhattacharya, who will be traveling to Philadelphia on Tuesday.
Pennsylvania is the fourth-largest recipient of NIH funding in the country and received $2.27 billion in federal research funding during the 2025 fiscal year.
That included $670 million in funding allocated to the University of Pittsburgh and UPMC.
The tour comes as the number of NIH grants has been reduced under the Trump administration, included 10 Pitt grants worth about $16.2 million terminated in early 2025.
Dr. Bhattacharya said the number of grants in the NIH portfolio has fallen from about 57,000 to 55,000, but the amount of funding per grant is larger. Both he and Mr. McCormick noted that Congress passed an NIH budget last year that included a 2% increase in funding.
Dr. Bhattacharya also said the NIH is focused on funding projects that are likely to improve public health rather than those driven by political agendas or projects he considers “DEI investments.”
“There were parts of our portfolio which were actually just political in nature that weren’t having any hope of improving health in people, and so we moved away from that towards things that actually have a chance of improving health,” he said.
The White House is reportedly expected to ask Congress to cut NIH spending by 20% in the president’s fiscal 2027 budget request, according to Roll Call.
Mr. McCormick said he would oppose any cuts to the NIH budget.
“I will be strong advocate for increasing the NIH budget again this year within Congress, so I’m not in favor of the president’s budget if, in fact, that is the case.”
Across the state, NIH funding supports more than 21,000 jobs and has generated more than $5.3 billion in annual economic activity, according to Mr. McCormick.
The funding also has helped launch thousands of businesses and created nearly 100,000 biopharmaceutical jobs across the state — while each dollar from NIH translates to $2.56 flowing back into the economy, Mr. McCormick said.
On Wednesday, after wrapping up the second leg of tour of Philadelphia, Mr. McCormick said he will travel to the Lehigh Valley to meet with FBI Director Kash Patel to discuss issues surrounding opioid addiction and violent crime.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.